Immunovant (IMVT) Exchange Rate Effect (2021 - 2026)
Immunovant (IMVT) reported Exchange Rate Effect of -$988000.0 for Q1 2026, down 102.46% on a YoY basis from $40.2 million in Q1 2025, and down 362.07% quarter-over-quarter from $377000.0 in Q4 2025.
Immunovant (IMVT) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Immunovant has reported Exchange Rate Effect for 6 years, with the latest figure at -$988000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 102.46% year-over-year to -$988000.0; the trailing twelve-month figure through Mar 2026 stood at -$299000.0 (down 140.03% YoY), and the FY2026 full-year result was -$299000.0, down 140.03% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$988000.0, down from $377000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $2.7 million in Q1 2024, with the low at -$1.6 million in Q4 2023.
- Historically, Exchange Rate Effect has averaged $91117.6 across 5 years, with a median of -$112000.0 in 2022.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect soared 13385.0% — and 2023, when it slumped 337.5%.
- Immunovant's Exchange Rate Effect stood at $2.7 million in 2022, then plunged by 159.55% to -$1.6 million in 2023, then surged by 90.72% to -$149000.0 in 2024, then surged by 353.02% to $377000.0 in 2025, then plunged by 362.07% to -$988000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$988000.0 (Q1 2026), $377000.0 (Q4 2025), and $878000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 8.68 Mn |
| 10 | Immunovant | 5.71 Bn | 5.71 Bn | - | -988,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -988,000.00 |
| Mar 31, 2026 | -988,000.00 |
| Dec 31, 2025 | 377,000.00 |
| Dec 31, 2025 | 377,000.00 |
| Sep 30, 2025 | 878,000.00 |
| Sep 30, 2025 | 878,000.00 |
| Jun 30, 2025 | -566,000.00 |
| Jun 30, 2025 | -566,000.00 |
| Mar 31, 2025 | -488,000.00 |
| Mar 31, 2025 | -488,000.00 |
| Dec 31, 2024 | -149,000.00 |
| Dec 31, 2024 | -149,000.00 |
| Sep 30, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 335,000.00 |
| Jun 30, 2024 | 335,000.00 |
| Mar 31, 2024 | 2.73 Mn |
| Mar 31, 2024 | 2.73 Mn |
| Dec 31, 2023 | -1.61 Mn |
| Dec 31, 2023 | -1.61 Mn |